Table 2.
Characteristic | β-coefficient | SE | OR (95% CI) | p value |
---|---|---|---|---|
Age (< 70 vs. ≥ 70 years) | 0.11 | 0.35 | 1.12 | 0.74 |
BMI (< 30 vs. ≥ 30 kg/m2) | 0.22 | 0.44 | 1.25 | 0.61 |
Gender (male vs. female) | 1.26 | 0.81 | 3.5 | 0.12 |
Medication (< 3 vs. ≥ 3 treatments) | 0.25 | 0.41 | 1.29 | 0.53 |
No adverse event (yes/no) | 1.8 | 0.39 | 6.07 | < 0.0001 |
SBP (< 130 vs. ≥ 130 mmHg) | 0.08 | 0.35 | 1.09 | 0.81 |
Vitamin D supplementation (yes/no) | 0.29 | 0.41 | 1.34 | 0.48 |
Statistically significant p-values are represented by bold text
BMI body mass index, CI confidence interval, OR odds ratio, SBP systolic blood pressure, SE standard error